The Effects of Bromelain Supplement in Patients With Ulcerative Colitis | MicrobiomeTrials← Back to trialsNCT06351696
The Effects of Bromelain Supplement in Patients With Ulcerative Colitis
CompletedPHASE2, PHASE3INTERVENTIONAL
Trial Details
Start: 2024-04-20Est. Completion: 2025-05-10
Enrollment target: 52 participants Locations- Azita Hekmatdoost, Tehran, Middle East, Iran
Other microbiome trials you might be interested in
Ulcerative ColitisInflammatory Bowel DiseasesColitisColitis, Ulcerative
This is a Phase 2, multicenter, proof-of-concept platform study in adult participants with moderately to severely active…
Canoga Park, United StatesEst. completion Jun 2027
Ulcerative ColitisInflammatory Bowel DiseasesColitisColitis, Ulcerative
This is a multicenter, long-term extension (LTE) study in participants with ulcerative colitis (UC) from Study SPY123-20…
Lancaster, United StatesCompleted Mar 2, 2029